Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Agenus Inc. (NASDAQ: AGEN).

Full DD Report for AGEN

You must become a subscriber to view this report.


Recent News from (NASDAQ: AGEN)

AgenTus Therapeutics to Present on the Anti-tumor Activities of Two Proprietary T Cell Receptors (TCRs) at CAR-TCR Summit in Boston, MA
LEXINGTON, Mass. , Sept. 5 , 2018 /PRNewswire/ -- AgenTus Therapeutics, a subsidiary of Agenus Inc. (NASDAQ: AGEN), dedicated to advancing breakthrough "living drugs" for potentially curative treatments for patients with cancer, announced today that Dr. Cherylene Plewa , Senior Dir...
Source: PR Newswire
Date: September, 05 2018 19:34
Agenus to Present at The Annual B. Riley FBR Healthcare Conference in New York City
LEXINGTON, Mass. , Sept. 4, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies 1 , announced today that Jennifer Buell , Ph.D., Chief Communications and Extern...
Source: PR Newswire
Date: September, 04 2018 09:57
Agenus: Buy Or Sell?
Agenus ( AGEN ) was founded in 1994 and is based in Lexington, MA. Shares have risen >30% last week since the idea was published to the subscribers of Vasuda Healthcare Analytics, marketplace service. Bull's case: (R&D pipeline, source company website) The company has a diverse...
Source: SeekingAlpha
Date: August, 26 2018 11:46
Midday Gainers / Losers (08/22/2018)
Gainers: YECO +56% . NEWA +30% . EXAS +26% . MYND +22% . PSTG +17% . AGEN +14% . LZB +12% . ADMP +12% . MYGN +11% . EPE +11% . More news on: Yulong Eco-Materials, Newater Technology, Inc., EXACT Sciences Corporation, Stocks on the move, , Read more ... ...
Source: SeekingAlpha
Date: August, 22 2018 12:45
Midday Gainers / Losers (08/21/2018)
Gainers: TAT +21% . KOSS +21% . UXIN +18% . LLEX +17% . AGFS +16% . AGEN +16% . RNN +16% . BLFS +15% . PINC +15% . GSB +15% . Losers: SEAC -42% . NEWA -38% . SITO -17% . GRIN -13% . COCP -12% . DAKT -10% . COTY -10% . BOSC -10% . ...
Source: SeekingAlpha
Date: August, 21 2018 12:55
Agenus earns second $4M milestone payment from Merck
Agenus ( AGEN -4.7% ) announces that it has received a $4M milestone payment from Merck ( MRK +0.5% ) triggered by the initiation of a Phase 1 clinical trial of an undisclosed antibody discovered by Agenus. More news on: Agenus, Merck & Co Inc., Healthcare stocks news, Read m...
Source: SeekingAlpha
Date: August, 15 2018 13:44
Agenus Receives Second Milestone Payment from Merck
LEXINGTON, Mass. , Aug. 15, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies 1 , announced today that Merck, known as MSD outside the United States and Can...
Source: PR Newswire
Date: August, 15 2018 13:22
Agenus (AGEN) CEO Garo Armen on Q2 2018 Results - Earnings Call Transcript
Agenus (AGEN) Q2 2018 Results Earnings Conference Call August 9, 2018, 08:30 AM ET Executives Jennifer Buell - Head-Communications and External Affairs Garo Armen - Chairman and CEO Sunil Gupta - Head of Regulatory and Pharmacovigilance Christine Klaskin - VP of Finance Anal...
Source: SeekingAlpha
Date: August, 09 2018 14:32
Agenus up 2% premarket on Q2 results
Agenus ( AGEN ) Q2 results : Revenues: $10.5M. More news on: Agenus, Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 09 2018 09:01
Agenus beats by $0.16, beats on revenue
Agenus (NASDAQ: AGEN ): Q2 EPS of -$0.24 beats by $0.16 . More news on: Agenus, Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 09 2018 08:03

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-082.012.022.03991.96725,536
2018-05-173.403.353.453.281,060,262
2017-06-203.503.863.983.502,703,624
2017-06-193.463.523.523.35749,490
2017-06-163.383.463.463.332,775,847

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-11153,349333,01246.0491Short
2018-12-10164,343296,54355.4196Short
2018-12-07295,194547,76553.8906Short
2018-12-0685,437201,72542.3532Short
2018-12-04158,373221,23471.5862Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AGEN.


About Agenus Inc. (NASDAQ: AGEN)

Logo for Agenus Inc. (NASDAQ: AGEN)

Not available

 

Contact Information

 

 

Current Management

  • Garo H. Armen / President, CEO
  • Shalini Sharp / CFO
  • Jonae Barnes / IR

Current Share Structure

  • Market Cap: $343,565,270 - 05/14/2018
  • Issue and Outstanding: 102,556,797 - 02/28/2018

 


Recent Filings from (NASDAQ: AGEN)

Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 26 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 15 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: March, 05 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: AGEN)

Daily Technical Chart for (NASDAQ: AGEN)


Stay tuned for daily updates and more on (NASDAQ: AGEN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AGEN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AGEN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AGEN and does not buy, sell, or trade any shares of AGEN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/